Denali Therapeutics (DNLI) Stock Price, Quote, News & History | Benzinga

Denali Therapeutics Inc (DNLI) Stock Price, Quote, News & History

DNLINASDAQ

Trade with Public

Trade with Public

$19.30

0.472.50%

At close: May 21, 5:00 PM EST

$17.32

-1.98-10.26%

After Hours: 7:56 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$18.55

Close

$19.30

Volume / Avg.

1.35M / 1.73M

Day Range

$18.35 - $19.33

52 Wk Range

12.58 - 23.77

Market Cap

$2.75B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

9.85%

Days to Cover

9.95

Recent Denali Therapeutics Inc News

Nancy Pelosi Stock Tracker Highlights Claude's Pharma Earnings Play: 'Will Be Interesting To See How This One Plays Out'

Nancy Pelosi Stock Tracker highlighted Claude AI's Denali Therapeutics earnings bet, which targets upside from its rare-disease drug launch.

Ananya Gairola

Takeda Exits Dementia Drug Partnership With Denali Therapeutics - Here's Why

Denali shares fall after Takeda exits DNL593 deal; company regains full rights and targets Phase 1/2 data readout by late 2026.

Vandana Singh

FDA Clears Denali Therapeutics Drug As First Brain-Penetrating Biologic For Rare Disease

Denali Therapeutic snags FDA accelerated approval for Avlayah for Hunter syndrome, analyst flags strong launch potential.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-412.34M

Investing Cash Flow (TTM)

330.99M

Financing Cash Flow (TTM)

412.02M

Free Cash Flow (TTM)

-419.23M

Capital Expenditure (TTM)

-6.89M

Net Change in Cash (TTM)

330.68M

Analyst Trends and Forecast

1

Feb

7

Mar

2

Apr

3

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.92B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.23

Earnings Yield % (TTM)

-15.29%

Earnings Yield % (FWD)

-15.08%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$5.84

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$3.83M

Total Cash

$387.63M

Debt to Equity

0.04

Issuance of Debt (TTM)

-$3.83M

Repayment of Debt (TTM)

-$3.83M

Key Statistics

Open

$18.55

Close

$19.30

Volume / Avg.

1.35M / 1.73M

Day Range

$18.35 - $19.33

52 Wk Range

12.58 - 23.77

Market Cap

$2.75B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

9.85%

Days to Cover

9.95

About

Sector

Health Care

Industry

Biotechnology

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Denali Therapeutics (DNLI) stock?

A

You can purchase shares of Denali Therapeutics (NASDAQ:DNLI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Denali Therapeutics (DNLI) competitors?

A

There are no as such competitors for Denali Therapeutics.

Q

What is the forecast, or price target, for Denali Therapeutics (DNLI) stock?

A

Denali Therapeutics has a consensus price target of $34.53.

Q

What is the current price for Denali Therapeutics (DNLI)?

A

The stock price for Denali Therapeutics (NASDAQ: DNLI) is $17.32 last updated May 21, 2026 at 7:56 PM EDT.

Q

Does Denali Therapeutics (DNLI) pay a dividend?

A

There are no upcoming dividends for Denali Therapeutics.

Q

When is Denali Therapeutics (NASDAQ:DNLI) reporting earnings?

A

Denali Therapeutics does not have any upcoming earnings scheduled.

Q

Is Denali Therapeutics (DNLI) going to split?

A

There is no upcoming split for Denali Therapeutics.

Q

What sector and industry does Denali Therapeutics (DNLI) operate in?

A

Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.